Marina Biotech Inc

Moderna Inc. a biotechnology company discovers develops and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases immuno-oncology rare diseases autoimmune and cardiovascular diseases in the United States Europe and internationally. Its respiratory vaccines include COVID-19 flu respiratory syncytial virus Endemic HCoV and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus epstein-barr virus herpes simplex virus varicella-zoster virus and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines such as personalized cancer KRAS and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative systemic intracellular and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi Inc.; Carisma Therapeutics Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics Inc. and changed its name to Moderna Inc. in August 2018. Moderna Inc. was founded in 2010 and is headquartered in Cambridge Massachusetts.